BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
![Foto de BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS](/img/grupo.png)
![Foto de Fremantle Hospital](/img/noimage_org.png)
Fremantle Hospital
Fremantle, AustraliaPublications in collaboration with researchers from Fremantle Hospital (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477